Beau Ventures
BMY icon

Beau Ventures’s Bristol-Myers Squibb BMY Stock Holding History

Beau Ventures’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.27M Sell
100,515
-67
-0.1% -$4.23K 0.59% 13
2026
Q2 		$5.8M Buy
100,582
+377
+0.4% +$21.6K 0.63% 13
2026
Q1 		$6.08M Buy
100,205
+138
+0.1% +$8.04K 0.81% 12
2025
Q4 		$5.4M Buy
+100,067
New +$4.81M 0.67% 13

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Beau Ventures's BMY Position: Q3 2026 in Review

Beau Ventures reduced its Bristol-Myers Squibb (BMY) stake by 0.07% in Q3 2026, selling an estimated $4.23K and leaving 100,515 shares worth $6.27M. The position accounts for 0.59% of the portfolio, ranked #13.

Beau Ventures first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 1,030 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Beau Ventures held 100,515 shares of Bristol-Myers Squibb worth $6.27M as of Q3 2026.
  • Beau Ventures sold 67 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.23K.
  • Bristol-Myers Squibb made up 0.59% of Beau Ventures's portfolio in Q3 2026, its #13 holding.
  • Beau Ventures first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 1,030 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Beau Ventures's 13F filing for Q3 2026, filed 14 Oct 2026.